Kim RD, Naleid N, Bubie A, Zhang N, et al. Real-world outcomes in circulating tumor DNA-detected isocitrate dehydrogenase 1-mutant cholangiocarcinoma: First-line gemcitabine and cisplatin with versus without immunotherapy. Cancer 2026;132:e70646.
PMID: 42876026